Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix structural constituent conferring tensile strength	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 COL15A1 COL27A1 COL22A1 COL24A1	1.10e-10	46	163	9	GO:0030020
GeneOntologyMolecularFunction	antigen binding	IGHV3-53 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	5.63e-09	190	163	13	GO:0003823
GeneOntologyMolecularFunction	extracellular matrix structural constituent	COL3A1 COL4A4 COL4A5 COL4A6 HSPG2 COL6A3 COL15A1 COL27A1 COL22A1 COL24A1 FBN2 AGRN	4.80e-08	188	163	12	GO:0005201
GeneOntologyMolecularFunction	semaphorin receptor activity	PLXND1 PLXNB2 PLXNA1	1.11e-04	12	163	3	GO:0017154
GeneOntologyMolecularFunction	calcium ion binding	HSPG2 PRSS3 ESYT1 FAT3 PCLO AOAH PCDHA7 ADGRV1 FBN2 NKD1 AOC3 NINL VWA2 AGRN PCDH7 SYT13 PADI3	1.39e-04	749	163	17	GO:0005509
GeneOntologyBiologicalProcess	B cell mediated immunity	IGHV3-53 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-13 IGHV3-7 LILRB1 APLF IGHV3-64D IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	7.91e-10	244	160	15	GO:0019724
GeneOntologyBiologicalProcess	immunoglobulin mediated immune response	IGHV3-53 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-13 IGHV3-7 APLF IGHV3-64D IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	4.46e-09	235	160	14	GO:0016064
GeneOntologyBiologicalProcess	leukocyte mediated immunity	IGHV3-53 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-13 IGHV3-7 LILRB1 APLF IGHV3-64D NCR3 NLRP6 MYO1F CTSG IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	1.17e-07	576	160	19	GO:0002443
GeneOntologyBiologicalProcess	lymphocyte mediated immunity	IGHV3-53 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-13 IGHV3-7 LILRB1 APLF IGHV3-64D NCR3 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	4.50e-07	449	160	16	GO:0002449
GeneOntologyBiologicalProcess	immune effector process	IGHV3-53 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-13 IGHV3-7 PTGER4 LILRB1 APLF IGHV3-64D NCR3 NLRP6 CD22 MYO1F CTSG IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	3.23e-06	859	160	21	GO:0002252
GeneOntologyBiologicalProcess	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	IGHV3-53 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-13 IGHV3-7 LILRB1 APLF IGHV3-64D IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	3.30e-06	462	160	15	GO:0002460
GeneOntologyCellularComponent	immunoglobulin complex	IGHV3-53 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	6.26e-10	166	163	13	GO:0019814
GeneOntologyCellularComponent	collagen trimer	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 COL15A1 COL27A1 COL22A1 COL24A1	2.88e-08	88	163	9	GO:0005581
GeneOntologyCellularComponent	basement membrane collagen trimer	COL4A4 COL4A5 COL4A6 COL15A1	2.43e-07	8	163	4	GO:0098651
GeneOntologyCellularComponent	complex of collagen trimers	COL3A1 COL4A4 COL4A5 COL4A6 COL27A1	4.99e-07	21	163	5	GO:0098644
GeneOntologyCellularComponent	collagen-containing extracellular matrix	COL3A1 COL4A4 COL4A5 COL4A6 HSPG2 COL6A3 PRSS3 COL15A1 COL27A1 COL22A1 PLXNB2 COL24A1 FBN2 CTSG VWA2 AGRN	4.18e-06	530	163	16	GO:0062023
GeneOntologyCellularComponent	collagen type IV trimer	COL4A4 COL4A5 COL4A6	9.15e-06	6	163	3	GO:0005587
GeneOntologyCellularComponent	network-forming collagen trimer	COL4A4 COL4A5 COL4A6	2.53e-05	8	163	3	GO:0098642
GeneOntologyCellularComponent	collagen network	COL4A4 COL4A5 COL4A6	2.53e-05	8	163	3	GO:0098645
GeneOntologyCellularComponent	basement membrane	COL4A4 COL4A5 COL4A6 HSPG2 COL15A1 VWA2 AGRN	4.87e-05	122	163	7	GO:0005604
GeneOntologyCellularComponent	extracellular matrix	COL3A1 COL4A4 COL4A5 COL4A6 HSPG2 COL6A3 PRSS3 COL15A1 COL27A1 COL22A1 PLXNB2 COL24A1 FBN2 CTSG VWA2 AGRN	5.70e-05	656	163	16	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	COL3A1 COL4A4 COL4A5 COL4A6 HSPG2 COL6A3 PRSS3 COL15A1 COL27A1 COL22A1 PLXNB2 COL24A1 FBN2 CTSG VWA2 AGRN	5.91e-05	658	163	16	GO:0030312
GeneOntologyCellularComponent	semaphorin receptor complex	PLXND1 PLXNB2 PLXNA1	1.26e-04	13	163	3	GO:0002116
GeneOntologyCellularComponent	endoplasmic reticulum lumen	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 COL15A1 COL27A1 COL22A1 COL24A1	1.22e-03	332	163	9	GO:0005788
GeneOntologyCellularComponent	inhibitory synapse	PCLO NLGN3 IGSF9B	1.78e-03	31	163	3	GO:0060077
HumanPheno	Anterior lenticonus	COL4A4 COL4A5 COL4A6	5.21e-07	3	42	3	HP:0011501
HumanPheno	Lenticonus	COL4A4 COL4A5 COL4A6	6.01e-05	10	42	3	HP:0001142
HumanPheno	Vaginal neoplasm	COL4A5 COL4A6 FH	6.01e-05	10	42	3	HP:0100650
HumanPheno	Tracheobronchial leiomyomatosis	COL4A5 COL4A6	6.64e-05	2	42	2	HP:0006524
HumanPheno	Dyspepsia	COL4A5 COL4A6	6.64e-05	2	42	2	HP:0410281
HumanPheno	Diffuse leiomyomatosis	COL4A5 COL4A6	6.64e-05	2	42	2	HP:0006756
HumanPheno	Abnormal vagina morphology	COL3A1 COL4A5 COL4A6 DYNC2H1 CYP11A1 NR0B1 FH	6.96e-05	128	42	7	HP:0000142
Domain	Collagen	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 COL15A1 COL27A1 COL22A1 COL24A1	2.38e-08	85	148	9	IPR008160
Domain	Collagen	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 COL15A1 COL27A1 COL22A1 COL24A1	2.38e-08	85	148	9	PF01391
Domain	Laminin_G	HSPG2 COL15A1 FAT3 COL27A1 COL22A1 COL24A1 AGRN	3.65e-07	58	148	7	IPR001791
Domain	ConA-like_dom	HSPG2 COL15A1 FAT3 COL27A1 COL22A1 ADGRV1 MAMDC4 COL24A1 PTPRK AGRN NEURL4	1.40e-06	219	148	11	IPR013320
Domain	C4	COL4A4 COL4A5 COL4A6	9.58e-06	6	148	3	SM00111
Domain	Collagen_VI_NC	COL4A4 COL4A5 COL4A6	9.58e-06	6	148	3	IPR001442
Domain	NC1_IV	COL4A4 COL4A5 COL4A6	9.58e-06	6	148	3	PS51403
Domain	-	COL4A4 COL4A5 COL4A6	9.58e-06	6	148	3	2.170.240.10
Domain	C4	COL4A4 COL4A5 COL4A6	9.58e-06	6	148	3	PF01413
Domain	LAM_G_DOMAIN	HSPG2 FAT3 COL27A1 COL24A1 AGRN	1.19e-05	38	148	5	PS50025
Domain	TSPN	COL15A1 COL27A1 COL22A1 COL24A1	2.98e-05	23	148	4	SM00210
Domain	Plexin_cytopl	PLXND1 PLXNB2 PLXNA1	3.96e-05	9	148	3	PF08337
Domain	Plexin_cytoplasmic_RasGAP_dom	PLXND1 PLXNB2 PLXNA1	3.96e-05	9	148	3	IPR013548
Domain	Plexin	PLXND1 PLXNB2 PLXNA1	3.96e-05	9	148	3	IPR031148
Domain	NC1_FIB	COL3A1 COL27A1 COL24A1	7.68e-05	11	148	3	PS51461
Domain	Fib_collagen_C	COL3A1 COL27A1 COL24A1	7.68e-05	11	148	3	PD002078
Domain	Fib_collagen_C	COL3A1 COL27A1 COL24A1	7.68e-05	11	148	3	IPR000885
Domain	COLFI	COL3A1 COL27A1 COL24A1	7.68e-05	11	148	3	PF01410
Domain	COLFI	COL3A1 COL27A1 COL24A1	7.68e-05	11	148	3	SM00038
Domain	TIG	PLXND1 PLXNB2 EXOC2 PLXNA1	1.01e-04	31	148	4	PF01833
Domain	IPT	PLXND1 PLXNB2 EXOC2 PLXNA1	1.15e-04	32	148	4	IPR002909
Domain	PDZ	GIPC1 MAGI1 SYNJ2BP PCLO GRID2IP SCRIB PATJ	2.03e-04	151	148	7	PS50106
Domain	PDZ	GIPC1 MAGI1 SYNJ2BP PCLO GRID2IP SCRIB PATJ	2.11e-04	152	148	7	IPR001478
Domain	Ig_2	HSPG2 LILRB1 SIGLEC7 CD22 IGSF9B	2.84e-04	73	148	5	PF13895
Domain	LamG	HSPG2 COL15A1 FAT3 AGRN	4.02e-04	44	148	4	SM00282
Domain	-	HSPG2 FLNB COL6A3 IGDCC3 PLXND1 PLXNB2 LILRB1 NCR3 SIGLEC7 PTPRK CD22 IGSF9B EXOC2 PLXNA1	8.12e-04	663	148	14	2.60.40.10
Domain	PDZ	GIPC1 MAGI1 SYNJ2BP GRID2IP SCRIB PATJ	9.12e-04	141	148	6	PF00595
Domain	-	HSPG2 FAT3 ADGRV1 COL24A1 AGRN	9.54e-04	95	148	5	2.60.120.200
Domain	PDZ	GIPC1 MAGI1 SYNJ2BP GRID2IP SCRIB PATJ	1.17e-03	148	148	6	SM00228
Domain	IPT	PLXND1 PLXNB2 PLXNA1	1.24e-03	27	148	3	SM00429
Domain	-	GIPC1 MAGI1 SYNJ2BP GRID2IP SCRIB PATJ	1.26e-03	150	148	6	2.30.42.10
Domain	Ig_E-set	FLNB PLXND1 PLXNB2 EXOC2 PLXNA1	1.43e-03	104	148	5	IPR014756
Domain	Ig-like_fold	HSPG2 FLNB COL6A3 IGDCC3 PLXND1 PLXNB2 LILRB1 NCR3 SIGLEC7 PTPRK CD22 IGSF9B EXOC2 PLXNA1	1.48e-03	706	148	14	IPR013783
Domain	Tim17/Tim22/Tim23/PMP24	TIMM23 TIMMDC1	1.69e-03	8	148	2	IPR003397
Domain	Tim17	TIMM23 TIMMDC1	1.69e-03	8	148	2	PF02466
Domain	Semap_dom	PLXND1 PLXNB2 PLXNA1	1.86e-03	31	148	3	IPR001627
Domain	SEMA	PLXND1 PLXNB2 PLXNA1	1.86e-03	31	148	3	PS51004
Domain	Sema	PLXND1 PLXNB2 PLXNA1	1.86e-03	31	148	3	SM00630
Domain	Sema	PLXND1 PLXNB2 PLXNA1	1.86e-03	31	148	3	PF01403
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D CD22 IGHV3-74 IGHV3-66 IGHV3-64	2.55e-15	35	116	11	MM17219
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D CD22 IGHV3-74 IGHV3-66 IGHV3-64	4.12e-13	53	116	11	MM15716
Pathway	REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-64	4.99e-13	39	116	10	MM17212
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D SCARB1 IGHV3-74 IGHV3-66 IGHV3-64	1.77e-12	60	116	11	MM14872
Pathway	REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-64	2.40e-12	45	116	10	MM14912
Pathway	REACTOME_FCGR_ACTIVATION	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-64	4.83e-12	48	116	10	MM17214
Pathway	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-64	1.70e-11	54	116	10	MM14655
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-64	2.49e-11	56	116	10	MM14815
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-64	3.60e-11	58	116	10	MM14914
Pathway	REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-64	5.12e-11	60	116	10	MM14913
Pathway	REACTOME_COLLAGEN_CHAIN_TRIMERIZATION	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 COL15A1 COL27A1 COL22A1 COL24A1	7.03e-11	44	116	9	M27812
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	COL3A1 IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D SIGLEC7 CD22 IGHV3-74 IGHV3-66 IGHV3-64	7.55e-11	135	116	13	MM14781
Pathway	REACTOME_COMPLEMENT_CASCADE	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-64	1.59e-09	84	116	10	MM14653
Pathway	REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 COL15A1 COL27A1 COL22A1 COL24A1	3.62e-09	67	116	9	M26999
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D CD22 IGHV3-74 IGHV3-66 IGHV3-64	1.00e-08	131	116	11	MM15717
Pathway	REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-64	1.73e-08	107	116	10	MM14915
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-64	3.19e-08	114	116	10	MM14814
Pathway	REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 COL15A1 COL27A1 COL24A1	3.37e-08	61	116	8	M27103
Pathway	REACTOME_COLLAGEN_CHAIN_TRIMERIZATION	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 COL15A1 COL22A1	3.80e-08	41	116	7	MM15538
Pathway	REACTOME_COLLAGEN_FORMATION	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 COL15A1 COL27A1 COL22A1 COL24A1	5.11e-08	90	116	9	M631
Pathway	REACTOME_COLLAGEN_DEGRADATION	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 PRSS3 COL15A1	2.40e-07	53	116	7	MM14566
Pathway	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 PRSS3 COL15A1 FBN2 CTSG	3.98e-07	114	116	9	MM14571
Pathway	REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-64	4.29e-07	150	116	10	MM14889
Pathway	REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 COL15A1 COL22A1	6.43e-07	61	116	7	MM14637
Pathway	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-64	6.93e-07	158	116	10	MM14812
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	COL3A1 COL4A4 COL4A5 COL4A6 HSPG2 COL6A3 COL15A1 COL27A1 COL22A1 COL24A1 FBN2 CTSG AGRN	1.10e-06	300	116	13	M610
Pathway	PID_SYNDECAN_1_PATHWAY	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 COL15A1	1.95e-06	46	116	6	M198
Pathway	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	COL3A1 COL4A4 COL4A5 COL4A6 HSPG2 COL6A3 COL15A1 FBN2 CTSG	2.25e-06	140	116	9	M587
Pathway	REACTOME_ECM_PROTEOGLYCANS	COL3A1 COL4A4 COL4A5 COL4A6 HSPG2 COL6A3 AGRN	2.91e-06	76	116	7	M27219
Pathway	REACTOME_COLLAGEN_FORMATION	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 COL15A1 COL22A1	2.91e-06	76	116	7	MM14573
Pathway	REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 COL15A1	3.22e-06	50	116	6	MM14796
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	COL3A1 IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7 LILRB1 NCR3 SIGLEC7 CD22	3.70e-06	190	116	10	M8240
Pathway	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	COL3A1 COL4A4 COL4A5 COL4A6 HSPG2 COL6A3 AGRN	6.19e-06	85	116	7	M16441
Pathway	REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	COL3A1 COL4A4 COL4A5 COL4A6 HSPG2 AGRN	8.61e-06	59	116	6	M27218
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 PRSS3 COL15A1 COL22A1 FBN2 CTSG AGRN	9.00e-06	258	116	11	MM14572
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7 CD22	1.05e-05	61	116	6	M27581
Pathway	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	COL3A1 COL4A4 COL4A5 COL6A3 SPTBN5 AGRN	1.26e-05	63	116	6	M11187
Pathway	REACTOME_COLLAGEN_DEGRADATION	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 COL15A1	1.39e-05	64	116	6	M26953
Pathway	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	COL3A1 COL4A4 COL4A5 COL6A3 SPTBN5	1.40e-05	38	116	5	MM14969
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	COL3A1 IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7 SCARB1	1.59e-05	98	116	7	M27152
Pathway	REACTOME_NCAM1_INTERACTIONS	COL3A1 COL4A4 COL4A5 COL6A3	1.90e-05	20	116	4	MM15061
Pathway	REACTOME_NCAM1_INTERACTIONS	COL3A1 COL4A4 COL4A5 COL6A3 AGRN	2.31e-05	42	116	5	M7169
Pathway	PID_AVB3_INTEGRIN_PATHWAY	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 COL15A1	3.20e-05	74	116	6	M160
Pathway	BIOCARTA_NPP1_PATHWAY	COL4A4 COL4A5 COL4A6	6.25e-05	10	116	3	M22040
Pathway	BIOCARTA_NPP1_PATHWAY	COL4A4 COL4A5 COL4A6	6.25e-05	10	116	3	MM1560
Pathway	KEGG_ECM_RECEPTOR_INTERACTION	COL3A1 COL4A4 COL4A6 HSPG2 COL6A3 AGRN	6.57e-05	84	116	6	M7098
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7 CD22	7.50e-05	86	116	6	M601
Pathway	BIOCARTA_VITCB_PATHWAY	COL4A4 COL4A5 COL4A6	8.54e-05	11	116	3	M15422
Pathway	REACTOME_LAMININ_INTERACTIONS	COL4A4 COL4A5 COL4A6 HSPG2	1.01e-04	30	116	4	M27216
Pathway	BIOCARTA_VITCB_PATHWAY	COL4A4 COL4A5 COL4A6	1.13e-04	12	116	3	MM1526
Pathway	REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	COL3A1 COL4A4 COL4A5 COL4A6	1.31e-04	32	116	4	MM14924
Pathway	BIOCARTA_ACE2_PATHWAY	COL4A4 COL4A5 COL4A6	1.46e-04	13	116	3	MM1347
Pathway	BIOCARTA_ACE2_PATHWAY	COL4A4 COL4A5 COL4A6	1.46e-04	13	116	3	M12950
Pathway	BIOCARTA_PLATELETAPP_PATHWAY	COL4A4 COL4A5 COL4A6	1.85e-04	14	116	3	MM1458
Pathway	BIOCARTA_PLATELETAPP_PATHWAY	COL4A4 COL4A5 COL4A6	1.85e-04	14	116	3	M6487
Pathway	PID_INTEGRIN1_PATHWAY	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3	2.07e-04	66	116	5	M18
Pathway	REACTOME_ANCHORING_FIBRIL_FORMATION	COL4A4 COL4A5 COL4A6	2.30e-04	15	116	3	M27161
Pathway	REACTOME_LAMININ_INTERACTIONS	COL4A4 COL4A5 COL4A6	2.30e-04	15	116	3	MM14922
Pathway	REACTOME_FCGR_ACTIVATION	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7	2.56e-04	69	116	5	M27108
Pathway	REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7	2.56e-04	69	116	5	M27150
Pathway	REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7	2.92e-04	71	116	5	M1078
Pathway	REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7	2.92e-04	71	116	5	M27203
Pathway	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3	4.01e-04	76	116	5	MM14867
Pathway	REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS	COL4A4 COL4A5 COL4A6	4.05e-04	18	116	3	M27164
Pathway	REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS	COL4A4 COL4A5 COL4A6	4.05e-04	18	116	3	MM14882
Pathway	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7	5.09e-04	80	116	5	M6121
Pathway	BIOCARTA_AMI_PATHWAY	COL4A4 COL4A5 COL4A6	5.59e-04	20	116	3	M15394
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7	5.70e-04	82	116	5	M27110
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7	7.09e-04	86	116	5	M27206
Pathway	REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7	7.47e-04	87	116	5	M27205
Pathway	BIOCARTA_INTRINSIC_PATHWAY	COL4A4 COL4A5 COL4A6	8.53e-04	23	116	3	M15997
Pathway	BIOCARTA_INTRINSIC_PATHWAY	COL4A4 COL4A5 COL4A6	8.53e-04	23	116	3	MM1427
Pathway	REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7	1.11e-03	95	116	5	M29842
Pathway	REACTOME_SIGNALING_BY_PDGF	COL3A1 COL4A4 COL4A5 COL6A3	1.23e-03	57	116	4	MM14713
Pathway	REACTOME_SIGNALING_BY_PDGF	COL3A1 COL4A4 COL4A5 COL6A3	1.31e-03	58	116	4	M2049
Pathway	REACTOME_NERVOUS_SYSTEM_DEVELOPMENT	COL3A1 COL4A4 COL4A5 COL6A3 PLXND1 SPTBN5 EFNB3 PLXNA1	1.41e-03	261	116	8	MM15676
Pathway	REACTOME_MET_ACTIVATES_PTK2_SIGNALING	COL3A1 COL27A1 COL24A1	1.87e-03	30	116	3	M27772
Pathway	REACTOME_VESICLE_MEDIATED_TRANSPORT	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D SPTBN5 SURF4 SCARB1 IGHV3-74 IGHV3-66 IGHV3-64	2.47e-03	645	116	13	MM15232
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7 CD22	2.49e-03	166	116	6	M608
Pathway	REACTOME_COMPLEMENT_CASCADE	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7	2.59e-03	115	116	5	M19752
Pathway	REACTOME_PARASITE_INFECTION	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7	2.69e-03	116	116	5	M29843
Pathway	REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY	SLC39A3 SLC39A5	2.89e-03	10	116	2	M27361
Pubmed	1.3 A X-ray structure of an antibody Fv fragment used for induced membrane-protein crystallization.	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-64	1.21e-20	15	164	10	12657787
Pubmed	Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response.	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-64	2.53e-18	22	164	10	2499654
Pubmed	IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes.	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	9.33e-14	77	164	11	15608191
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	COL3A1 COL4A4 COL4A5 COL4A6 HSPG2 COL6A3 PRSS3 COL15A1 COL27A1 COL22A1 PLXNB2 COL24A1 FBN2 AGRN	1.35e-13	175	164	14	28071719
Pubmed	Structure and physical map of 64 variable segments in the 3'0.8-megabase region of the human immunoglobulin heavy-chain locus.	IGHV3-53 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-7 IGHV3-64	1.12e-11	39	164	8	8490662
Pubmed	The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus.	IGHV3-53 IGHV3-48 IGHV3-35 IGHV3-20 IGHV3-16 IGHV3-7 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	1.91e-11	91	164	10	9841928
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	COL3A1 COL4A4 COL4A5 COL4A6 HSPG2 COL6A3 COL15A1 COL27A1 PLXNB2 COL24A1 AGRN	4.89e-10	167	164	11	22159717
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	COL3A1 COL4A5 COL4A6 HSPG2 COL6A3 COL15A1 COL24A1 FBN2 CTSG AGRN	9.79e-10	135	164	10	28675934
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	COL4A5 SDSL HSPG2 ESYT1 PLXND1 NCLN FHIP1B PLXNB2 SYNE4 TFE3 CCDC142 EHBP1L1 KMT2D WIZ PIK3C2B RBM19 SCARB1 NINL AKAP13 LTK FEM1A AGRN PLXNA1	2.66e-09	1105	164	23	35748872
Pubmed	Interaction between Alzheimer's disease beta A4 precursor protein (APP) and the extracellular matrix: evidence for the participation of heparan sulfate proteoglycans.	COL4A4 COL4A5 COL4A6 HSPG2	9.79e-08	10	164	4	9136074
Pubmed	Binding of mouse and human fibulin-2 to extracellular matrix ligands.	COL4A4 COL4A5 COL4A6 HSPG2	1.53e-07	11	164	4	7500359
Pubmed	Matrilin-2 interacts with itself and with other extracellular matrix proteins.	COL4A4 COL4A5 COL4A6 FBN2	2.29e-07	12	164	4	12180907
Pubmed	Compound genetic ablation of nidogen 1 and 2 causes basement membrane defects and perinatal lethality in mice.	COL4A4 COL4A5 COL4A6 HSPG2	2.29e-07	12	164	4	16024816
Pubmed	Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.	COL3A1 COL4A4 COL4A6 HSPG2 COL6A3 COL15A1 COL24A1 CTSG	7.13e-07	153	164	8	25037231
Pubmed	Identification of a novel cell-adhesive protein spatiotemporally expressed in the basement membrane of mouse developing hair follicle.	COL4A4 COL4A5 COL4A6 HSPG2	8.30e-07	16	164	4	15878328
Pubmed	Molecular analysis of spontaneous somatic mutants.	IGHV3-48 IGHV3-13 IGHV3-7	1.02e-06	5	164	3	401950
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	COL3A1 GIPC1 COL4A4 COL4A5 COL4A6 HSPG2 COL15A1 ESYT1 PLXND1 NCLN PLXNB2 FBN2 PTPRK ABCE1 SURF4 SCARB1 SCRIB AGRN PCDH7 PLXNA1	1.09e-06	1201	164	20	35696571
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	CYC1 HSPG2 TIMM23 PFKP NCLN PLXNB2 LRRC47 FBN2 PPT2 CCT5 ABCE1 SCARB1 ARIH1 PLXNA1	1.41e-06	613	164	14	22268729
Pubmed	Stimulation of extracellular matrix components in the normal brain by invading glioma cells.	COL4A4 COL4A5 COL4A6	2.04e-06	6	164	3	9506531
Pubmed	Extracellular matrix of the human optic nerve head.	COL4A4 COL4A5 COL4A6	2.04e-06	6	164	3	2426947
Pubmed	Angiogenesis and collagen type IV expression in different endothelial cell culture systems.	COL4A4 COL4A5 COL4A6	2.04e-06	6	164	3	23551189
Pubmed	Monoclonal antibody to human basement membrane collagen type IV.	COL4A4 COL4A5 COL4A6	2.04e-06	6	164	3	6811420
Pubmed	Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas.	COL4A4 COL4A5 COL4A6	2.04e-06	6	164	3	6389236
Pubmed	Collagen IV in the developing lens capsule.	COL4A4 COL4A5 COL4A6	2.04e-06	6	164	3	12225806
Pubmed	Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome.	COL4A4 COL4A5 COL4A6	2.04e-06	6	164	3	10534397
Pubmed	A tumor derived motility factor that stimulates cell migration on extracellular matrix.	COL4A4 COL4A5 COL4A6	2.04e-06	6	164	3	9673377
Pubmed	Localization of type IV collagen a 1 to a 6 chains in basement membrane during mouse molar germ development.	COL4A4 COL4A5 COL4A6	2.04e-06	6	164	3	11732842
Pubmed	Developmental distribution of collagen IV isoforms and relevance to ocular diseases.	COL4A4 COL4A5 COL4A6	2.04e-06	6	164	3	19275937
Pubmed	Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin.	COL4A4 COL4A5 COL4A6	2.04e-06	6	164	3	6988303
Pubmed	Transcriptome-based systematic identification of extracellular matrix proteins.	COL4A4 COL4A5 COL4A6 HSPG2 COL15A1 AGRN	2.10e-06	79	164	6	18757743
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	CDC42BPG TICRR FLNB PCLO BMS1 IGDCC3 ACVR1B PFKP GFPT1 LRRC47 WIZ ABCE1 AKAP13 IGSF9B SCRIB	2.38e-06	736	164	15	29676528
Pubmed	Interstitial collagens I, III, and VI sequester and modulate the multifunctional cytokine oncostatin M.	COL4A4 COL4A5 COL4A6	3.55e-06	7	164	3	11711546
Pubmed	Regulation of protease nexin-1 target protease specificity by collagen type IV.	COL4A4 COL4A5 COL4A6	3.55e-06	7	164	3	8006028
Pubmed	Corneal cell proteins and ocular surface pathology.	COL4A4 COL4A5 COL4A6	3.55e-06	7	164	3	10416788
Pubmed	Purification, partial characterization of rat kidney hyaluronic acid binding protein and its localization on the cell surface.	COL4A4 COL4A5 COL4A6	3.55e-06	7	164	3	1724753
Pubmed	Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.	COL3A1 HSPG2 COL6A3 FBN2 AGRN	3.91e-06	50	164	5	23658023
Pubmed	Appearance and persistence of fibronectin in cartilage. Specific interaction of fibronectin with collagen type II.	COL4A4 COL4A5 COL4A6	5.67e-06	8	164	3	3997552
Pubmed	Type IV collagen α6 chain is a regulator of keratin 10 in keratinization of oral mucosal epithelium.	COL4A4 COL4A5 COL4A6	5.67e-06	8	164	3	29422532
Pubmed	Mice develop normally without tenascin.	COL4A4 COL4A5 HSPG2	5.67e-06	8	164	3	1383086
Pubmed	Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth.	COL4A4 COL4A5 COL4A6	5.67e-06	8	164	3	10382266
Pubmed	Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation.	COL3A1 HSPG2 COL6A3 COL15A1 CTSG AGRN	6.95e-06	97	164	6	27559042
Pubmed	MMP-9 from TNF alpha-stimulated keratinocytes binds to cell membranes and type I collagen: a cause for extended matrix degradation in inflammation?	COL4A4 COL4A5 COL4A6	8.47e-06	9	164	3	9878537
Pubmed	Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling.	COL4A4 COL4A5 COL4A6	8.47e-06	9	164	3	12101409
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	CYC1 DYNC2H1 ESYT1 SRM TIMM23 GPRC5C PFKP NCLN TIMMDC1 PLXNB2 GFPT1 LRRC47 CTPS2 PTPRK SURF4 SCRIB	1.08e-05	942	164	16	31073040
Pubmed	Proteomic characterization of human multiple myeloma bone marrow extracellular matrix.	COL3A1 COL4A5 COL4A6 COL27A1 CTSG	1.14e-05	62	164	5	28344315
Pubmed	Content and organization of the human Ig VH locus: definition of three new VH families and linkage to the Ig CH locus.	IGHV3-13 IGHV3-72 IGHV3-66	1.21e-05	10	164	3	3396540
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	COL3A1 HSPG2 COL6A3 COL15A1 AGRN	1.34e-05	64	164	5	22261194
Pubmed	Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development.	COL4A4 COL4A5 COL4A6	1.65e-05	11	164	3	14998921
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	CYC1 COL3A1 HSPG2 FLNB PRSS3 ESYT1 ACAD10 MCCC2 COQ3 PFKP NCLN TIMMDC1 PLXNB2 GFPT1 NARS2 PTPRK ALDH1L2 SURF4 AGRN PLXNA1	1.79e-05	1451	164	20	30550785
Pubmed	Basement membrane fragility underlies embryonic lethality in fukutin-null mice.	COL4A4 COL4A5 COL4A6	2.20e-05	12	164	3	15837576
Pubmed	Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina.	PLXND1 PLXNB2 PLXNA1	2.20e-05	12	164	3	21270798
Pubmed	EP4 receptor-associated protein regulates gluconeogenesis in the liver and is associated with hyperglycemia in diabetic mice.	PTGER4 FEM1A	2.21e-05	2	164	2	30562059
Pubmed	Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma.	HSPG2 AGRN	2.21e-05	2	164	2	25506919
Pubmed	The clinical spectrum of type IV collagen mutations.	COL4A4 COL4A5	2.21e-05	2	164	2	9195222
Pubmed	Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors.	COL4A5 COL4A6	2.21e-05	2	164	2	8356449
Pubmed	EP4 Receptor-Associated Protein in Macrophages Ameliorates Colitis and Colitis-Associated Tumorigenesis.	PTGER4 FEM1A	2.21e-05	2	164	2	26439841
Pubmed	Alport syndrome and leiomyomatosis: the first deletion extending beyond COL4A6 intron 2.	COL4A5 COL4A6	2.21e-05	2	164	2	21380622
Pubmed	Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.	COL4A4 COL4A5	2.21e-05	2	164	2	28632965
Pubmed	Tissue- and developmental stage-specific activation of alpha 5 and alpha 6(IV) collagen expression in the upper gastrointestinal tract of transgenic mice.	COL4A5 COL4A6	2.21e-05	2	164	2	14592452
Pubmed	Differential expression of mouse alpha5(IV) and alpha6(IV) collagen genes in epithelial basement membranes.	COL4A5 COL4A6	2.21e-05	2	164	2	10965041
Pubmed	Immunohistochemical localization of type IV collagen alpha chains in the basement membrane of the pancreatic duct in human normal pancreas and pancreatic diseases.	COL4A5 COL4A6	2.21e-05	2	164	2	15211113
Pubmed	Chinese family with diffuse oesophageal leiomyomatosis: a new COL4A5/COL4A6 deletion and a case of gonosomal mosaicism.	COL4A5 COL4A6	2.21e-05	2	164	2	26179878
Pubmed	Modification of an aggressive model of Alport Syndrome reveals early differences in disease pathogenesis due to genetic background.	COL4A4 COL4A5	2.21e-05	2	164	2	31892712
Pubmed	Isolation, structural characterization, and chromosomal mapping of the mouse vascular adhesion protein-1 gene and promoter.	COL15A1 AOC3	2.21e-05	2	164	2	9743358
Pubmed	Plexin-B2 and Plexin-D1 in dendritic cells: expression and IL-12/IL-23p40 production.	PLXND1 PLXNB2	2.21e-05	2	164	2	22916243
Pubmed	Characterization of contiguous gene deletions in COL4A6 and COL4A5 in Alport syndrome-diffuse leiomyomatosis.	COL4A5 COL4A6	2.21e-05	2	164	2	28275241
Pubmed	Clonal overgrowth of esophageal smooth muscle cells in diffuse leiomyomatosis-Alport syndrome caused by partial deletion in COL4A5 and COL4A6 genes.	COL4A5 COL4A6	2.21e-05	2	164	2	20951201
Pubmed	Loss of expression of type IV collagen alpha5 and alpha6 chains in colorectal cancer associated with the hypermethylation of their promoter region.	COL4A5 COL4A6	2.21e-05	2	164	2	16507901
Pubmed	Variable region sequences of five human immunoglobulin heavy chains of the VH3 subgroup: definitive identification of four heavy chain hypervariable regions.	IGHV3-23 IGHV3-7	2.21e-05	2	164	2	4522793
Pubmed	Bifunctional promoter of type IV collagen COL4A5 and COL4A6 genes regulates the expression of alpha5 and alpha6 chains in a distinct cell-specific fashion.	COL4A5 COL4A6	2.21e-05	2	164	2	15598179
Pubmed	Quantifying domain-ligand affinities and specificities by high-throughput holdup assay.	MAGI1 SYNJ2BP SCRIB PATJ	2.50e-05	36	164	4	26053890
Pubmed	Mesangial cells organize the glomerular capillaries by adhering to the G domain of laminin alpha5 in the glomerular basement membrane.	COL4A4 HSPG2 AGRN	2.84e-05	13	164	3	12682087
Pubmed	Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates.	PLXND1 PLXNB2 PLXNA1	2.84e-05	13	164	3	10520995
Pubmed	FOXD1 is required for 3D patterning of the kidney interstitial matrix.	COL4A4 HSPG2 FBN2	2.84e-05	13	164	3	36335435
Pubmed	Abnormal expression of collagen IV in lens activates unfolded protein response resulting in cataract.	COL4A4 COL4A5 COL4A6	3.61e-05	14	164	3	19858219
Pubmed	Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors.	COL4A4 COL4A5 COL4A6	3.61e-05	14	164	3	12878203
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	CYC1 GIPC1 FLNB DRG2 ESYT1 BMS1 SRM MCCC2 PFKP NCLN PLXNB2 GFPT1 PPT2 CCT5 SURF4 SCARB1 AKAP13 ARIH1	4.42e-05	1297	164	18	33545068
Pubmed	Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.	ADGRV1 ZCCHC2 COQ3 NCLN FHIP1B TIMMDC1 GASK1B ENKD1 PPT2 RBM19 SURF4 PLXNA1 SYT13	6.11e-05	750	164	13	11230166
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MAGI1 DRG2 ESYT1 PFKP NCKAP5L ENKD1 NARS2 ITPKB PIK3C2B GIGYF2 AKAP13 SCRIB PATJ PCDH7	6.28e-05	861	164	14	36931259
Pubmed	Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome.	COL4A4 COL4A5	6.61e-05	3	164	2	27576055
Pubmed	Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome.	COL4A4 COL4A5	6.61e-05	3	164	2	15954103
Pubmed	Alport syndrome: impact of digenic inheritance in patients management.	COL4A4 COL4A5	6.61e-05	3	164	2	27859054
Pubmed	Sixteen novel mutations identified in COL4A3, COL4A4, and COL4A5 genes in Slovenian families with Alport syndrome and benign familial hematuria.	COL4A4 COL4A5	6.61e-05	3	164	2	17396119
Pubmed	A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers.	COL4A4 COL4A5	6.61e-05	3	164	2	24522496
Pubmed	The localization and secretion of type IV collagen in synovial capillaries by immunohistochemistry using a monoclonal antibody against human type IV collagen.	COL4A5 COL4A6	6.61e-05	3	164	2	6386565
Pubmed	Collagen IV alpha 3, alpha 4, and alpha 5 chains in rodent basal laminae: sequence, distribution, association with laminins, and developmental switches.	COL4A4 COL4A5	6.61e-05	3	164	2	7962065
Pubmed	Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome.	COL4A4 COL4A5	6.61e-05	3	164	2	28542346
Pubmed	Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.	COL4A4 COL4A5	6.61e-05	3	164	2	28704582
Pubmed	Identification of noncollagenous sites encoding specific interactions and quaternary assembly of alpha 3 alpha 4 alpha 5(IV) collagen: implications for Alport gene therapy.	COL4A4 COL4A5	6.61e-05	3	164	2	18930919
Pubmed	Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS.	COL4A4 COL4A5	6.61e-05	3	164	2	30647093
Pubmed	Autism-linked NLGN3 is a key regulator of gonadotropin-releasing hormone deficiency.	PLXND1 NLGN3	6.61e-05	3	164	2	36810932
Pubmed	Structure analyses reveal a regulated oligomerization mechanism of the PlexinD1/GIPC/myosin VI complex.	GIPC1 PLXND1	6.61e-05	3	164	2	28537552
Pubmed	Four novel mutations identified in the COL4A3, COL4A4 and COL4A5 genes in 10 families with Alport syndrome.	COL4A4 COL4A5	6.61e-05	3	164	2	38978054
Pubmed	Alport Syndrome	COL4A4 COL4A5	6.61e-05	3	164	2	20301386
Pubmed	Stabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance.	MAGI1 SCRIB	6.61e-05	3	164	2	21489588
Pubmed	MLL histone methylases regulate expression of HDLR-SR-B1 in presence of estrogen and control plasma cholesterol in vivo.	KMT2D SCARB1	6.61e-05	3	164	2	23192982
Pubmed	Genetic Variants of the COL4A3 , COL4A4 , and COL4A5 Genes Contribute to Thinned Glomerular Basement Membrane Lesions in Sporadic IgA Nephropathy Patients.	COL4A4 COL4A5	6.61e-05	3	164	2	36130833
Pubmed	A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- Alport mice.	COL4A4 COL4A5	6.61e-05	3	164	2	14507670
Pubmed	Genetic diagnosis of Alport syndrome in 16 Chinese families.	COL4A4 COL4A5	6.61e-05	3	164	2	38433557
Pubmed	Evidence of digenic inheritance in Alport syndrome.	COL4A4 COL4A5	6.61e-05	3	164	2	25575550
Cytoband	14q32.33	IGHV3-53 IGHV3-48 IGHV3-35 NUDT14 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	2.50e-12	228	164	13	14q32.33
Cytoband	Ensembl 112 genes in cytogenetic band chr14q32	IGHV3-53 IGHV3-48 IGHV3-35 NUDT14 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	1.95e-08	566	164	14	chr14q32
Cytoband	5q23-q31	FBN2 NEUROG1	1.27e-05	2	164	2	5q23-q31
GeneFamily	Collagens	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 COL15A1 COL27A1 COL22A1 COL24A1	9.56e-12	46	113	9	490
GeneFamily	Immunoglobulin heavy locus at 14q32.33	IGHV3-53 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	2.09e-09	187	113	12	349
GeneFamily	Plexins	PLXND1 PLXNB2 PLXNA1	1.94e-05	9	113	3	683
GeneFamily	PDZ domain containing	GIPC1 MAGI1 SYNJ2BP PCLO GRID2IP SCRIB PATJ	4.74e-05	152	113	7	1220
GeneFamily	Ataxins\|Trinucleotide repeat containing	MAGI1 KMT2D GIGYF2	4.95e-04	25	113	3	775
GeneFamily	Blood group antigens\|CD molecules\|Proteoglycans	HSPG2 AGRN	7.97e-04	7	113	2	570
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	PCLO APLF	3.85e-03	15	113	2	26
Coexpression	XU_CREBBP_TARGETS_DN	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-64	1.61e-12	56	161	10	MM642
Coexpression	NABA_COLLAGENS	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 COL15A1 COL27A1 COL22A1 COL24A1	4.69e-12	43	161	9	MM17060
Coexpression	NABA_COLLAGENS	COL3A1 COL4A4 COL4A5 COL4A6 COL6A3 COL15A1 COL27A1 COL22A1 COL24A1	5.86e-12	44	161	9	M3005
Coexpression	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-64	7.57e-10	102	161	10	MM872
Coexpression	NABA_BASEMENT_MEMBRANES	COL4A4 COL4A5 COL4A6 HSPG2 COL6A3 COL15A1 AGRN	4.55e-09	40	161	7	M5887
Coexpression	RASHI_RESPONSE_TO_IONIZING_RADIATION_6	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-66 IGHV3-64	9.47e-09	132	161	10	MM996
Coexpression	NABA_CORE_MATRISOME	COL3A1 COL4A4 COL4A5 COL4A6 HSPG2 COL6A3 COL15A1 COL27A1 COL22A1 COL24A1 FBN2 VWA2 AGRN	1.36e-08	270	161	13	MM17057
Coexpression	NABA_CORE_MATRISOME	COL3A1 COL4A4 COL4A5 COL4A6 HSPG2 COL6A3 COL15A1 COL27A1 COL22A1 COL24A1 FBN2 VWA2 AGRN	1.69e-08	275	161	13	M5884
Coexpression	NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER	COL4A6 COL22A1 PLXNB2 COL24A1 AGRN	5.15e-06	41	161	5	M47988
Coexpression	DESCARTES_FETAL_INTESTINE_VASCULAR_ENDOTHELIAL_CELLS	HSPG2 COL15A1 GASK1B SPTBN5 RP1L1	6.55e-06	43	161	5	M40215
Coexpression	HEBERT_MATRISOME_TNBC_LUNG_METASTASIS	COL3A1 COL4A4 COL4A5 HSPG2	1.11e-05	23	161	4	M48001
Coexpression	MATTIOLI_MGUS_VS_PCL	IGHV3-23 IGHV3-20 IGHV3-7 ESYT1 LILRB1 ABCE1 IGHV3-72	1.40e-05	127	161	7	M10973
Coexpression	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN	COL3A1 COL6A3 ABCE1 SCARB1 ARIH1 AGRN	2.40e-05	93	161	6	M4752
Coexpression	GSE39022_LN_VS_SPLEEN_DC_UP	TICRR ATF5 ESYT1 PAQR4 PLXND1 CD22 UPP1 IGSF9B	3.34e-05	199	161	8	M9017
Coexpression	GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_DN	GIPC1 DRG2 AOAH SRM TACC2 GASK1B ABCE1 RBM19	3.46e-05	200	161	8	M6449
Coexpression	NABA_MATRISOME	COL3A1 COL4A4 COL4A5 COL4A6 HSPG2 COL6A3 PRSS3 COL15A1 COL27A1 COL22A1 PLXND1 PLXNB2 COL24A1 FBN2 CTSG VWA2 AGRN PLXNA1	5.05e-05	1008	161	18	MM17056
Coexpression	NABA_MATRISOME	COL3A1 COL4A4 COL4A5 COL4A6 HSPG2 COL6A3 PRSS3 COL15A1 COL27A1 COL22A1 PLXND1 PLXNB2 COL24A1 FBN2 CTSG VWA2 AGRN PLXNA1	6.34e-05	1026	161	18	M5889
Coexpression	SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN	IGHV3-48 IGHV3-7 IGHV3-74	1.20e-04	16	161	3	M41742
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-53 COL4A4 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-7 ALDH1L2 LTK IGHV3-72 IGHV3-64	3.36e-12	179	164	12	494febe77c6d4e6a2c6f0928bbf4c84b0301f188
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 SRM ALDH1L2 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	1.04e-11	197	164	12	1e63879633f20646e44873ae6b662f6faf4806fd
ToppCell	BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-53 COL4A4 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 SRM ALDH1L2 IGHV3-72 IGHV3-66 IGHV3-64	7.46e-11	180	164	11	6a777a308fa3160d31eda468db930e71862020b2
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-13 IGHV3-7 IGHV3-64D ALDH1L2 IGHV3-66 IGHV3-64	7.92e-11	181	164	11	e47664a264a2c37390d1668ce04eef2e0172f4cb
ToppCell	Mild_COVID-19-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGHV3-53 COL4A4 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-7 NCR3 PTPRK CD22 IGHV3-66 IGHV3-64	8.91e-11	183	164	11	dea119e2988e954475f557f0bbe12556a83e81a4
ToppCell	10x5'-Liver-Lymphocytic_B_plasma\|Liver / Manually curated celltypes from each tissue	IGHV3-53 IGHV3-48 ATF5 IGHV3-23 IGHV3-7 SRM IGHV3-64D ALDH1L2 IGHV3-74 IGHV3-72 IGHV3-64	1.06e-10	186	164	11	a2c7430781f432c9c90ac4d620f4518ff767a223
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	1.33e-10	190	164	11	79ee6d10dfbb775da149a1104da5823cf63bbb46
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	1.33e-10	190	164	11	18762ce78ed0b206ade19e1c8ff76a2647489f68
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell-IgM_Plasmablast\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-13 IGHV3-7 ALDH1L2 IGHV3-74 IGHV3-72 IGHV3-64	1.58e-10	193	164	11	7b4b0271e4fbece703876acb053ae236afb7cdba
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-48 TICRR IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-7 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	1.67e-10	194	164	11	6ef4aeb8d8e35e4df58ff2a8256caa2113291de9
ToppCell	COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast\|COVID_vent / Disease condition, Lineage, Cell class and subclass	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 ALDH1L2 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	1.86e-10	196	164	11	026a06d8d2089806823e6f6453d3ede84ae93bc6
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-53 COL4A4 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-7 IGHV3-74 IGHV3-72 IGHV3-64	1.33e-09	179	164	10	837ed81f18257f444eaeadc4fac89deedd4e3061
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-53 COL4A4 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-7 IGHV3-74 IGHV3-72 IGHV3-64	1.33e-09	179	164	10	b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL3A1 COL4A4 COL4A5 COL4A6 HSPG2 COL6A3 COL15A1 GASK1B AOC3 KCNT1	1.41e-09	180	164	10	39ae8586efd91536e9ac6408d26de7e6d6237c41
ToppCell	Mild-Lymphoid-B-\|Mild / Condition, Lineage, Cell class and cell subclass	COL4A4 IGHV3-48 IGHV3-23 IGHV3-7 IGHV3-64D NCR3 PTPRK CD22 IGHV3-72 IGHV3-66	1.65e-09	183	164	10	b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60
ToppCell	Mild-Lymphoid-B\|Mild / Condition, Lineage, Cell class and cell subclass	COL4A4 IGHV3-48 IGHV3-23 IGHV3-7 IGHV3-64D NCR3 PTPRK CD22 IGHV3-72 IGHV3-66	1.65e-09	183	164	10	9b64d2d143525e6f48a191facfd101462ff36324
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGHV3-53 COL4A4 IGHV3-48 IGHV3-23 IGHV3-7 IGHV3-64D NCR3 PTPRK CD22 IGHV3-66	1.84e-09	185	164	10	609080adb2cfb105bb7b8efb617553833299f371
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 SRM IGHV3-64D ALDH1L2 IGHV3-74 IGHV3-64	1.84e-09	185	164	10	79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-13 IGHV3-7 SRM IGHV3-74 IGHV3-66	1.84e-09	185	164	10	1704a12153a9b107bf03ecccd1a036cf61334d7a
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 SRM IGHV3-64D ALDH1L2 IGHV3-74 IGHV3-64	1.84e-09	185	164	10	0fff2608f507e019ebb69c27e58fd5be3b049bef
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-13 IGHV3-7 SRM IGHV3-74 IGHV3-66	1.84e-09	185	164	10	08bc817908076734d66f2805cb954141f2cc5a18
ToppCell	Mild_COVID-19-B_cell-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGHV3-53 COL4A4 IGHV3-48 IGHV3-23 IGHV3-7 NCR3 PTPRK CD22 IGHV3-66 IGHV3-64	1.93e-09	186	164	10	855a5a00ba2aa1b5c63b8db56d026ddecc546050
ToppCell	healthy_donor-Lymphocytic-Plasma_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	IGHV3-53 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-7 COL24A1 IGHV3-74 IGHV3-66 IGHV3-64	2.14e-09	188	164	10	bd53b0371154cff680226897b61c9809a239d1b6
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	2.76e-09	193	164	10	282b47dae6043eabb1e13d41d91c07b5ec21cd65
ToppCell	Biopsy_IPF-Immune-Plasma_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-7 SRM IGHV3-74 IGHV3-72 IGHV3-66	3.21e-09	196	164	10	a1b6a8000b86efcb07843998aa3a49bb1f54bcda
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 CD22 IGHV3-74 IGHV3-72 IGHV3-66	3.37e-09	197	164	10	2662138671262b30508c5759038bcdcfe6551696
ToppCell	healthy_donor-Lymphocytic-Plasma_cell-IgM_Plasmablast\|healthy_donor / Disease condition, Lineage, Cell class and subclass	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-16 COL24A1 CTSG IGHV3-74 IGHV3-66 IGHV3-64	1.18e-08	166	164	9	2b7b580bec8d9467b0deaf97098065f72dbf2a4f
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGHV3-53 COL4A4 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-7 IGHV3-74 IGHV3-64	2.06e-08	177	164	9	4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGHV3-53 COL4A4 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-7 IGHV3-74 IGHV3-64	2.06e-08	177	164	9	d746122bf8d208c3aa4d156e8c12d0a0e555c6e5
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGHV3-53 COL4A4 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-7 IGHV3-74 IGHV3-64	2.06e-08	177	164	9	fc40918825b7e1eb6861df59dfca944778a64b98
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGHV3-53 COL4A4 IGHV3-48 IGHV3-23 IGHV3-7 NCR3 PTPRK CD22 IGHV3-66	2.89e-08	184	164	9	64bede8db709fd32f40c03265b96f0b12155bb8a
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGHV3-53 COL4A4 IGHV3-48 IGHV3-23 IGHV3-7 NCR3 PTPRK CD22 IGHV3-66	2.89e-08	184	164	9	3f8a359e40bebe58545f708682e5e5d1b70cf5cb
ToppCell	COVID-19-Lymphoid-Plasma,_B_cells\|COVID-19 / Condition, Lineage and Cell class	COL4A4 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-7 OXCT2 IGHV3-74 IGHV3-66 IGHV3-64	4.35e-08	193	164	9	bffd97a73365e1dd23ff3b0320b4860f04ec091a
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-48 ATF5 IGHV3-23 IGHV3-20 COL24A1 ALDH1L2 GLIS1 IGHV3-64	4.35e-08	193	164	9	5c5543e7c83ecea44d23521246592c0301044173
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-7 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	4.35e-08	193	164	9	34f6c13884fdf7f8a87f942fcb36a58cfac3f65d
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66 IGHV3-64	4.55e-08	194	164	9	a4a70369541876e1192df8828b63e3d1746ae3d9
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-7 SLC12A3 IGHV3-72 IGHV3-66 IGHV3-64	4.76e-08	195	164	9	13f4ee21568fd747608412d33559d10561dbb3c8
ToppCell	Biopsy_Other_PF-Immune-Plasma_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	IGHV3-53 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-20 IGHV3-7 IGHV3-72 IGHV3-66 IGHV3-64	4.76e-08	195	164	9	d0305c6a68c9e361507b04db94f86873085d49b3
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-16 IGHV3-7 IGHV3-74 IGHV3-72 IGHV3-66 IGHV3-64	4.76e-08	195	164	9	f3f7f1a77a1edd2b50a8211c76fe289738eb04cf
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A4 IGHV3-48 IGHV3-23 IGHV3-7 NCR3 CD22 IGHV3-74 IGHV3-72 IGHV3-66	5.19e-08	197	164	9	da175e66d0a743a1b91d46f224b5ff1d37aa5410
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 CD22 IGHV3-66 IGHV3-64	5.19e-08	197	164	9	9fe1b757f76c2d43d39aa9ac500eaba98723985c
ToppCell	Control-Control-Lymphocyte-B-Plasmablast\|Control / Disease, condition lineage and cell class	COL4A4 IGHV3-48 IGHV3-23 IGHV3-7 OXCT2 ALDH1L2 LTK IGHV3-74 IGHV3-64	5.66e-08	199	164	9	c11aa8bca3723a886e7082ae48bb922dd8396be4
ToppCell	10x5'-blood-Lymphocytic_B_plasma\|blood / Manually curated celltypes from each tissue	IGHV3-48 IGHV3-20 IGHV3-16 IGHV3-13 IGHV3-7 ALDH1L2 IGHV3-74 IGHV3-64	8.90e-08	150	164	8	6bab0a8bf78ed7de9e1b67ede7496488f80f4863
ToppCell	healthy_donor-Lymphocytic-Plasma_cell-IgG_Plasmablast\|healthy_donor / Disease condition, Lineage, Cell class and subclass	IGHV3-53 COL4A4 IGHV3-35 IGHV3-20 IGHV3-16 IGHV3-7 IGHV3-74 IGHV3-72	9.86e-08	152	164	8	a2ba2d95ac9010e1a62db34dcad10d004f8a90cc
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	COL3A1 COL4A5 COL4A6 HSPG2 COL6A3 COL15A1 COL22A1 INMT	1.39e-07	159	164	8	92049a8d8fc9997d8d0d76500c72596a9b2394e0
ToppCell	3'_v3-blood-Lymphocytic_B_plasma-Plasma_cells\|blood / Manually curated celltypes from each tissue	COL4A4 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-7 OXCT2 IGHV3-74 IGHV3-64	1.85e-07	165	164	8	1c0c24fe252b761cf879b83562e23c02f0b6489f
ToppCell	367C-Lymphocytic-Plasma_cell-\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-7 AMER2 IGHV3-72 IGHV3-66	2.03e-07	167	164	8	f2185eb72f0137136f6d71af2a70168fded6c940
ToppCell	367C-Lymphocytic-Plasma_cell\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-7 AMER2 IGHV3-72 IGHV3-66	2.03e-07	167	164	8	5e768cf24699893e05d1bcb1c92dba2336943a64
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A4 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-7 IGHV3-64D PTPRK IGHV3-64	2.23e-07	169	164	8	307571e57c3bfdf15f0fe1a8b36585e8e4f8a207
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A4 IGHV3-48 IGHV3-23 IGHV3-7 IGHV3-64D PTPRK CD22 IGHV3-64	2.33e-07	170	164	8	ee2ee67d90ae4596de8ccd620e37c82cf51651d4
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A4 IGHV3-48 IGHV3-23 IGHV3-7 IGHV3-64D PTPRK CD22 IGHV3-64	2.33e-07	170	164	8	d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A4 IGHV3-48 IGHV3-23 IGHV3-7 IGHV3-64D PTPRK CD22 IGHV3-64	2.33e-07	170	164	8	52787f6d529c285d9f0c04cc022710ead5b89b3f
ToppCell	COPD-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-7 IGHV3-64D IGHV3-64	2.91e-07	175	164	8	d73ee324479172501481b54967a0f3bd870fcf3a
ToppCell	Control-Lymphoid_P\|Control / Disease group, lineage and cell class	COL4A4 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-7 OXCT2 IGHV3-74	3.04e-07	176	164	8	d895a6b295cd649273ff80ad7785a3e0ae4c728a
ToppCell	Control-Lymphoid_P-Plasmablast\|Control / Disease group, lineage and cell class	COL4A4 IGHV3-48 IGHV3-35 IGHV3-23 IGHV3-16 IGHV3-7 OXCT2 IGHV3-74	3.04e-07	176	164	8	4b4416f342b732d2cc60133838728880326257d8
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7 ALDH1L2 IGHV3-74 IGHV3-72 IGHV3-64	3.17e-07	177	164	8	c2b0fb5921eea24d248d6e6ccb57c29b0832602c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7 ALDH1L2 IGHV3-74 IGHV3-72 IGHV3-64	3.17e-07	177	164	8	111fb0707ff37ca631d85bb5a09e067ffe568eb8
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-13 IGHV3-7 CD22 IGHV3-74 IGHV3-66	3.31e-07	178	164	8	107dae8b00c4257697a63700e72bb434cdb8406f
ToppCell	10x5'-GI_small-bowel-Lymphocytic_B_plasma\|GI_small-bowel / Manually curated celltypes from each tissue	COL4A4 IGHV3-48 IGHV3-23 IGHV3-7 SLC22A17 COL24A1 ALDH1L2 IGHV3-64	3.76e-07	181	164	8	9b33f531c8ac776706ec7e2d47e95ba30b6ce13c
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL4A4 IGHV3-48 IGHV3-23 IGHV3-7 NCR3 PTPRK CD22 IGHV3-66	3.76e-07	181	164	8	700adfb41e4e377530f0dd31be89e12f109f3469
ToppCell	10x5'-GI_small-bowel-Lymphocytic_B_plasma-Plasma_cells\|GI_small-bowel / Manually curated celltypes from each tissue	COL4A4 IGHV3-48 IGHV3-23 IGHV3-7 SLC22A17 COL24A1 ALDH1L2 IGHV3-64	3.76e-07	181	164	8	a0549a8c2b5b30e91fae3052f398e48baa45d7ff
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 ALDH1L2 IGHV3-72 IGHV3-64	4.08e-07	183	164	8	a6866951866373a1029e04818f4a4a31278c409d
ToppCell	10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells\|Liver / Manually curated celltypes from each tissue	IGHV3-48 IGHV3-23 IGHV3-7 IGHV3-64D ALDH1L2 IGHV3-74 IGHV3-72 IGHV3-64	4.26e-07	184	164	8	6f70d8f8ab8362d51f8a58735d42223e06566397
ToppCell	mild_COVID-19-Plasmablast\|mild_COVID-19 / disease group, cell group and cell class (v2)	IGHV3-48 TICRR IGHV3-20 OXCT2 IGHV3-64D ALDH1L2 IGHV3-66 IGHV3-64	4.62e-07	186	164	8	a639d2183b85b1be6e6da2b2e112aec5149d5bcd
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL3A1 COL4A4 COL4A5 HSPG2 COL15A1 COL24A1 NLGN3 PCDH7	4.81e-07	187	164	8	ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-53 IGHV3-23 IGHV3-13 IGHV3-7 SRM IGHV3-74 IGHV3-72 IGHV3-66	5.01e-07	188	164	8	6844cebca177fdf38b21a40d606230a033717a3a
ToppCell	3'_v3-bone_marrow-Lymphocytic_B_plasma\|bone_marrow / Manually curated celltypes from each tissue	IGHV3-53 ATF5 IGHV3-23 IGHV3-7 SRM ALDH1L2 IGHV3-74 IGHV3-72	5.22e-07	189	164	8	dceb011216deb4ffd830144a53c635c05dff5ec5
ToppCell	BAL-Severe-Lymphocyte-B\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A4 IGHV3-23 IGHV3-20 IGHV3-7 OXCT2 SRM IGHV3-72 IGHV3-64	5.43e-07	190	164	8	e82fefea5ac03470d10463832d3efd2380895860
ToppCell	BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A4 IGHV3-23 IGHV3-20 IGHV3-7 OXCT2 SRM IGHV3-72 IGHV3-64	5.43e-07	190	164	8	7fbaf46bf24d46543047582f0d262f3523e28eb4
ToppCell	BAL-Severe-Lymphocyte-B-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A4 IGHV3-23 IGHV3-20 IGHV3-7 OXCT2 SRM IGHV3-72 IGHV3-64	5.43e-07	190	164	8	9560722facaf3516936fcbc2a900a405fd85e5d0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A5 COL4A6 IGDCC3 GPRC5C COL22A1 PLXNB2 AGRN PCDH7	5.65e-07	191	164	8	7235a4d1601c88a2c8af571a2c04ab56d32f1b9a
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 HSPG2 COL6A3 COL15A1 GASK1B FBN2 ABCA6 PCDH7	5.88e-07	192	164	8	e4a7f2673f801b008ca67291db2fb2b9fd2955b8
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL3A1 COL4A4 COL6A3 COL15A1 COL27A1 PTGER4 NKD1 ABCA6	5.88e-07	192	164	8	9093a9e94a25682d109a7f6edc256a25a61103a0
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 HSPG2 COL6A3 COL15A1 GASK1B FBN2 ABCA6 PCDH7	5.88e-07	192	164	8	8937a59f6bbe07f671bdabbd3707dc9c17a14cd9
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL3A1 COL4A4 COL6A3 COL15A1 COL27A1 PTGER4 NKD1 ABCA6	5.88e-07	192	164	8	9ed5d49621ec1aa01716dc369bba1450b5f015f5
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 HSPG2 COL6A3 COL15A1 GASK1B FBN2 ABCA6 PCDH7	5.88e-07	192	164	8	ac1477433704573f95111eee6263b93668d2845e
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 ALDH1L2 GLIS1 IGHV3-74 IGHV3-64	6.61e-07	195	164	8	0b0615553b9a1b60d666d074ce4260919e2d5642
ToppCell	droplet-Limb_Muscle-MUSCLE-1m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL4A5 HSPG2 COL6A3 COL15A1 SRM FBN2 AOC3	6.61e-07	195	164	8	fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-13 IGHV3-7 SLC12A3 IGHV3-72	6.61e-07	195	164	8	df009b18898c10686f75cf72b4ec0eff18f5bb50
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	COL3A1 COL4A5 COL4A6 HSPG2 COL6A3 COL15A1 INMT	6.69e-07	134	164	7	b959899c89d3a0363a3cd2309155280e0fe5ba88
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-B\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-53 IGHV3-48 IGHV3-23 IGHV3-20 CD22 ALDH1L2 IGHV3-74 IGHV3-64	6.87e-07	196	164	8	fc67d8aad1ec4d7f98ffe44fb103e230b9b42c35
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-13 IGHV3-7 IGHV3-74 IGHV3-66	6.87e-07	196	164	8	fec21383435779bf4c632decd3d29c6ca7baebfb
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-7 IGHV3-72 IGHV3-66 IGHV3-64	6.87e-07	196	164	8	c38e7f533c619afe008de0e99042f7180c2da918
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL3A1 COL6A3 COL15A1 FAT3 NKD1 ABCA6 INMT AOC3	6.87e-07	196	164	8	42e9828222a9663525d571633e8a454c30bfa7f8
ToppCell	Biopsy_Control_(H.)-Immune-Plasma_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	IGHV3-53 IGHV3-23 IGHV3-20 IGHV3-16 IGHV3-13 IGHV3-7 ALDH1L2 IGHV3-66	7.14e-07	197	164	8	275f38ed7e477000e864cecf9b7d49ae134c3b6a
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell-IgG_Plasmablast\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	IGHV3-53 COL4A4 IGHV3-48 IGHV3-23 IGHV3-7 SRM ALDH1L2 IGHV3-66	7.14e-07	197	164	8	b754fad4f3caae6de95df901fd96ea8697fe41b1
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL4A5 HSPG2 COL6A3 ATF5 COL15A1 SRM SURF4	7.41e-07	198	164	8	1b90d632e59c3c47b936e829cceeb0334f05f34f
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL4A5 HSPG2 COL6A3 ATF5 COL15A1 SRM TIMM23	7.41e-07	198	164	8	5e70246a9ce199cb2fb5379912b8ab59456219e4
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL3A1 COL4A5 HSPG2 COL6A3 ATF5 COL15A1 SRM AOC3	7.41e-07	198	164	8	b086af292a508a156266c2d899ba1caf820bf61c
ToppCell	ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	COL3A1 FLNB COL6A3 COL15A1 PTGER4 GASK1B ABCA6 PCDH7	7.70e-07	199	164	8	56d72da6a5fab9cbb2975fe6f87a631debaba6a8
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	COL3A1 COL6A3 FAT3 NKD1 ABCA6 INMT AOC3 PCDH7	8.00e-07	200	164	8	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL3A1 COL6A3 FAT3 NKD1 ABCA6 INMT AOC3 PCDH7	8.00e-07	200	164	8	a510deaada669e690329183e18df02870bd204b3
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL3A1 COL6A3 FAT3 NKD1 ABCA6 INMT AOC3 PCDH7	8.00e-07	200	164	8	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1\|Thalamus / BrainAtlas - Mouse McCarroll V32	COL3A1 COL4A5 COL4A6 COL6A3 COL15A1 COL22A1 INMT	1.63e-06	153	164	7	e9c6fb5c41adb6595c66c3a917fe455348279e54
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1\|Thalamus / BrainAtlas - Mouse McCarroll V32	COL3A1 COL4A5 COL4A6 COL6A3 COL15A1 COL22A1 INMT	1.63e-06	153	164	7	b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_TIP\|Thalamus / BrainAtlas - Mouse McCarroll V32	COL3A1 COL4A5 COL4A6 COL6A3 COL15A1 COL22A1 INMT	1.63e-06	153	164	7	2513edfae62a44e51d3556675a096723194c966c
ToppCell	facs-Marrow-KLS-18m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAGI1 HSPG2 ADGRV1 SLC26A1 NLGN3 PTPRK KCNT1	1.70e-06	154	164	7	37765512dfae557b9f6eb30a29463b93682a4404
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL3A1 COL6A3 FAT3 IGDCC3 COL24A1 ABCA6 PCDH7	2.02e-06	158	164	7	e5636c0b608d68bd426a2b446ac508e4512e86a4
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	COL3A1 COL4A5 COL4A6 COL6A3 COL15A1 INMT	2.85e-06	107	164	6	13af691c8533418d2800a8eca61155896b559948
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	COL3A1 COL4A5 COL4A6 COL6A3 COL15A1 INMT	2.85e-06	107	164	6	a5a34bb9706527799ddb494d4f1bfc634c29e8a9
Drug	GK-101	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1	3.18e-09	36	149	7	CID000161853
Drug	Madecassol	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1	1.93e-08	46	149	7	CID000108062
Drug	BAPN	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1 AOC3	2.09e-08	71	149	8	CID000001647
Drug	AC1NMZ1B	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 PTGER4 COL24A1	3.24e-08	75	149	8	CID005034185
Drug	d-indobufen	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1	3.52e-08	50	149	7	CID000044562
Drug	ridogrel	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1	4.67e-08	52	149	7	CID005362391
Drug	NSC49633	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1	5.35e-08	53	149	7	CID000023340
Drug	halofuginone lactate	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 TFE3 COL24A1	8.76e-08	85	149	8	CID000062891
Drug	L-lysyl-L-lysyl-L-lysine	COL3A1 COL4A5 COL4A6 COL6A3 PRSS3 COL27A1 COL22A1 COL24A1 EFNB3 CTSG	1.18e-07	162	149	10	CID000072363
Drug	AC1LAKND	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1	1.62e-07	62	149	7	CID000470146
Drug	3-phenyllactic acid	SDSL FLNB ATF5 OXCT2 GFPT1 NEUROG1	1.94e-07	39	149	6	CID000003848
Drug	DMSe	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 OXCT2 COL22A1 COL24A1 UPP1	2.21e-07	132	149	9	CID000020796
Drug	malotilate	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1	4.18e-07	71	149	7	CID000004006
Drug	AC1L1C2F	COL3A1 COL4A5 COL4A6 HSPG2 COL6A3 COL27A1 COL22A1 COL24A1	6.50e-07	110	149	8	CID000001711
Drug	Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A	ACAD10 ACVR1B ERN2 LILRB1 GASK1B ITPKB EHBP1L1 SIGLEC7 RBM19 AKAP13	6.88e-07	196	149	10	7025_UP
Drug	strontium ranelate	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1	7.32e-07	77	149	7	CID006918182
Drug	PPACK	COL3A1 COL4A5 COL4A6 COL6A3 PRSS3 COL27A1 COL22A1 COL24A1	7.98e-07	113	149	8	CID003036757
Drug	4-hydroxyproline	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1	2.28e-06	91	149	7	CID000000825
Drug	isodesmosine	COL3A1 COL6A3 COL27A1 FBN2 NEUROG1	2.30e-06	33	149	5	CID000013811
Drug	ticlopidine	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1	5.23e-06	103	149	7	CID000005472
Drug	(2s,5s)-5-Carboxymethylproline	COL3A1 COL4A5 COL4A6 HSPG2 COL6A3 COL27A1 COL22A1 ACVR1B COL24A1 CD22 PLXNA1	7.35e-06	314	149	11	CID000447989
Drug	hydroxylysine	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1	7.61e-06	109	149	7	CID000001029
Drug	hyaluronan	COL3A1 COL4A5 COL4A6 HSPG2 COL6A3 PRSS3 COL27A1 COL22A1 COL24A1 FBN2	9.53e-06	263	149	10	CID000024759
Drug	AC1L9732	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1	1.02e-05	114	149	7	CID000439300
Drug	Tranilast sodium	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1	1.08e-05	115	149	7	CID000005527
Drug	chondroitin sulfate	COL3A1 COL4A5 COL4A6 HSPG2 COL6A3 PRSS3 COL27A1 OXCT2 COL22A1 COL24A1 CTSG AGRN	1.84e-05	413	149	12	CID000024766
Drug	Selara	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1	1.87e-05	125	149	7	CID000150310
Drug	AC1L1DD6	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1 CTSG	2.42e-05	179	149	8	CID000002299
Drug	thapsigargin; Down 200; 0.1uM; PC3; HT_HG-U133A	HSPG2 COL6A3 ZCCHC2 ITPKB EHBP1L1 PIK3C2B ABCE1 PLXNA1	2.42e-05	179	149	8	7103_DN
Drug	Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; HL60; HG-U133A	ATF5 PTGER4 NARS2 ABCE1 SCARB1 SCRIB CTSG PLXNA1	2.42e-05	179	149	8	1398_DN
Drug	desmosine	COL3A1 COL6A3 COL27A1 FBN2 CTSG	2.50e-05	53	149	5	CID000025435
Drug	pirfenidone	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1	3.54e-05	138	149	7	CID000040632
Drug	12(S)-hydroxyeicosatetraenoic acid	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1 PIK3C2B	3.57e-05	189	149	8	CID000001413
Drug	DL-penicillamine	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1	3.70e-05	139	149	7	CID000004727
Drug	PCR 4099	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1	3.70e-05	139	149	7	CID000002806
Drug	prostacyclin sodium salt	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 PTGER4 COL24A1 CTSG	4.12e-05	250	149	9	CID000000159
Drug	AC1NDSSF	PFKP FBN2	4.25e-05	2	149	2	CID004631017
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	MAGI1 DYNC2H1 SLC22A17 ITPKB WIZ EFNB3 RBM19 AKAP13	4.62e-05	196	149	8	3268_DN
Drug	Ambroxol hydrochloride [23828-92-4]; Up 200; 9.6uM; PC3; HT_HG-U133A	TACC2 ACVR1B SPTBN5 WIZ ABCA6 AOC3 SCRIB PATJ	4.79e-05	197	149	8	6719_UP
Drug	alpha-Santonin [481-06-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A	PCLO PLXND1 EHBP1L1 WIZ EFNB3 NDUFAF7 UPP1 PCDH7	4.79e-05	197	149	8	3877_DN
Drug	candesartan cilexetil	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1	4.85e-05	145	149	7	CID000002540
Drug	dermatan sulfate	COL3A1 COL4A5 HSPG2 COL6A3 PRSS3 COL27A1 OXCT2 CTSG	1.04e-04	220	149	8	CID000032756
Drug	khellin	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1	1.37e-04	171	149	7	CID000003828
Drug	AC1Q6PCP	COL3A1 COL4A5 COL4A6 COL6A3 COL27A1 COL22A1 COL24A1 SLC12A3	1.41e-04	230	149	8	CID000005267
Disease	myopathy (implicated_via_orthology)	COL4A4 COL4A5 COL4A6 FLNB COL15A1	5.52e-06	48	156	5	DOID:423 (implicated_via_orthology)
Disease	fibroblast growth factor 8 isoform A measurement	IGHV3-7 IGHV3-64D	2.78e-05	2	156	2	EFO_0020385
Disease	Leiomyomatosis, esophageal and vulval, with nephropathy	COL4A5 COL4A6	2.78e-05	2	156	2	C1839884
Disease	Leiomyoma, Epithelioid	COL4A5 COL4A6	2.78e-05	2	156	2	C0086533
Disease	collagen disease (implicated_via_orthology)	COL4A4 COL4A5 COL4A6	3.08e-05	12	156	3	DOID:854 (implicated_via_orthology)
Disease	5-methyluridine (ribothymidine) measurement	PCLO APLF UPP1	5.06e-05	14	156	3	EFO_0020013
Disease	dynein light chain 1, cytoplasmic measurement	IGHV3-7 IGHV3-64D	8.30e-05	3	156	2	EFO_0020339
Disease	Alport syndrome	COL4A4 COL4A5	8.30e-05	3	156	2	cv:C1567741
Disease	Collagen IV-related nephropathies	COL4A4 COL4A5	8.30e-05	3	156	2	cv:CN076135
Disease	developmental disorder of mental health (implicated_via_orthology)	PLXND1 PLXNB2 RASAL3 GIGYF2	1.32e-04	49	156	4	DOID:0060037 (implicated_via_orthology)
Disease	depressive symptom measurement, stressful life event measurement	PCLO MCCC2 ZCCHC2 PCDH7	1.43e-04	50	156	4	EFO_0007006, EFO_0007781
Disease	Hematuria, Benign Familial	COL4A4 COL4A5	1.65e-04	4	156	2	C0241908
Disease	Alport Syndrome	COL4A4 COL4A5	1.65e-04	4	156	2	C1567741
Disease	Renal glomerular disease	COL4A4 COL4A5 SLC12A3	2.38e-04	23	156	3	C0268731
Disease	Glomerulopathy Assessment	COL4A4 COL4A5 SLC12A3	2.38e-04	23	156	3	C4521256
Disease	Alport Syndrome, X-Linked	COL4A4 COL4A5	2.75e-04	5	156	2	C1567742
Disease	Alport Syndrome, Autosomal Dominant	COL4A4 COL4A5	2.75e-04	5	156	2	C1567743
Disease	Alport Syndrome, Autosomal Recessive	COL4A4 COL4A5	2.75e-04	5	156	2	C1567744
Disease	intraocular pressure measurement	COL6A3 DYNC2H1 PCLO ACAD10 COL24A1 FBN2 ABCA6 AKAP13 EXOC2 NALF2	3.97e-04	509	156	10	EFO_0004695
Disease	retinal detachment	FAT3 COL22A1	5.73e-04	7	156	2	EFO_0005773
Disease	Nonsyndromic Deafness	ADGRV1 SYNE4 NARS2 MYO1F	9.12e-04	81	156	4	C3711374
Disease	intracranial aneurysm (is_implicated_in)	COL22A1 KMT2D	1.77e-03	12	156	2	DOID:10941 (is_implicated_in)
Disease	breastfeeding duration	ZCCHC2 FBN2	2.42e-03	14	156	2	EFO_0006864
Disease	generalised epilepsy	ACVR1B PTPRK PCDH7	2.65e-03	52	156	3	EFO_0005917
Disease	Familial thoracic aortic aneurysm and aortic dissection	COL3A1 COL4A5 FBN2	2.80e-03	53	156	3	C4707243
Disease	Myasthenic Syndromes, Congenital, Slow Channel	GFPT1 AGRN	3.17e-03	16	156	2	C0751885
Disease	Congenital Myasthenic Syndromes, Postsynaptic	GFPT1 AGRN	3.59e-03	17	156	2	C0751883
Disease	response to antipsychotic drug	DYNC2H1 COL22A1 PCDH7	3.98e-03	60	156	3	GO_0097332
Disease	Colorectal Carcinoma	COL3A1 COL4A6 MCF2L2 LRRC47 AMER2 FBN2 SIGLEC7 ABCA6 ABCE1 VWA2	4.28e-03	702	156	10	C0009402
Disease	allergic sensitization measurement	NKD1 IGHV3-72 IGHV3-64	4.36e-03	62	156	3	EFO_0005298
Disease	Congenital Myasthenic Syndromes, Presynaptic	GFPT1 AGRN	4.48e-03	19	156	2	C0751884
Disease	osteochondrodysplasia (is_implicated_in)	HSPG2 FLNB	4.48e-03	19	156	2	DOID:2256 (is_implicated_in)
Disease	diet measurement, HOMA-B	MAGI1 FAT3	4.48e-03	19	156	2	EFO_0004469, EFO_0008111
Disease	urinary microalbumin measurement	COL4A4 TIMMDC1	4.96e-03	20	156	2	EFO_0010967

Protein segments in the cluster

Peptide	Gene	Start	Entry
GELRLGLDGTSVPLG	SYT13	256	Q7L8C5
LLAGQTGPGGVVGLD	MAMDC4	401	Q6UXC1
SAGTGLGEELVGLGP	ERC2-IT1	66	O76042
RGEGTGVLGSLSLPL	ESYT1	866	Q9BSJ8
PGVIDLFGGLGGLLE	BAAT	161	Q14032
EGRAPGGGLILPGSL	AMER2	216	Q8N7J2
GLSGLKGERGFPGLL	COL4A6	71	Q14031
GLKGDEGIQGLRGPS	COL4A6	371	Q14031
EGIQGLRGPSGVPGL	COL4A6	376	Q14031
PGAGEILERGQRGVG	ENKD1	61	Q9H0I2
GETVIGRGPLLGITD	APLF	21	Q8IW19
LGGIVNLPDGGITGI	CATSPERE	316	Q5SY80
GGVLGVLGEGGILST	BPIFB4	206	P59827
LLLAGSGGSGPRGVQ	ACVR1B	16	P36896
IIPGSGGIAGQRLSE	ALDH1L2	646	Q3SY69
LDVGCGGGLLTEPLG	COQ3	151	Q9NZJ6
GGGLLTEPLGRLGAS	COQ3	156	Q9NZJ6
QEGEILGLLGPNGAG	ABCA6	1311	Q8N139
GALRVGDGPRVLGES	AGRN	1736	O00468
LQGLVSGNLGGTLGP	AKAP13	2431	Q12802
AITDGPGILRIGAGI	ADGRV1	1456	Q8WXG9
GELGLVGDPGLFGLI	COL4A4	326	P53420
LGPGRGFEIAQGRLG	ACAD10	901	Q6JQN1
GSGPQLGTGRGTLRL	GIPC1	231	O14908
EGDLLPGLLGLVGGV	CCDC142	271	Q17RM4
ASLRGVVLGPRGAGL	CYC1	6	P08574
PIILGGLGNSEGNVG	BMS1	906	Q14692
VCVLLVGRGGDGGEP	AOC3	21	Q16853
EVLGGALEGGLPVGG	ATF5	41	Q9Y2D1
GVSGPRQLRLAGTIG	NKD1	46	Q969G9
RGLGPGSAVLGRVAL	RASAL3	371	Q86YV0
GSLGRVLLPEGGITA	RBM19	611	Q9Y4C8
GGHLRPGIVQSGGVV	HSPG2	3526	P98160
PSRGGLGEALGAVEL	CDC42BPG	1271	Q6DT37
GRLTGLGGEDLPTIV	NCLN	206	Q969V3
ELVEPGLGVGGERDG	ARIH1	46	Q9Y4X5
GSQPRGIILLGDSAG	AOAH	251	P28039
LAPRVGGTGGAVREL	PCDHA7	566	Q9UN72
VLQPGRDGAGLGLSG	FHIP1B	881	Q8N612
SGGGLIQPGGSLRLS	IGHV3-66	26	A0A0C4DH42
SGGGLVQPGGSLRLS	IGHV3-72	26	A0A0B4J1Y9
RLLAVGGLGAGGEVL	KLHL34	426	Q8N239
EAGSRIPGLGRITGL	PNLIPRP3	176	Q17RR3
ESGEGLVQPGGSLRL	IGHV3-64	26	A0A075B6Q5
GRPIGVEGIQVLGTG	IGDCC3	276	Q8IVU1
KRGPQGELGVTVLGG	MAGI1	21	Q96QZ7
EVLGLGVGTGNGTRL	NCR3	111	O14931
ETLRLADQGLPGGGA	NEUROG1	146	Q92886
NEEVPGGGIITGIGR	MCCC2	111	Q9HCC0
LARRGLGGGELSPEG	NCKAP5L	501	Q9HCH0
SGPGGGLVEEGELIE	NUDT14	166	O95848
PGGLQGDTLIDIGSG	INMT	51	O95050
LNGGLEGSREGSLPG	CSRNP1	466	Q96S65
SGGGLVQPGGSLRLS	IGHV3-7	26	P01780
PGGLGQGGLAATLRD	GALNT9	91	Q9HCQ5
LTGPGLEERVRAAGG	LRRC47	26	Q8N1G4
GNILITGPDSQGLGR	ERN2	641	Q76MJ5
SGGGLVQPGGSLRLS	IGHV3-13	26	P01766
LLPARGGGSVGSDVG	KCNT1	36	Q5JUK3
AIDGIGGLGIGEGAP	DNAAF10	116	Q96MX6
SGGGLVQPGGSLRLS	IGHV3-48	26	P01763
RAGELEPLLVAAGGG	LTK	221	P29376
ILSGGRGEDGAPIIT	MCF2L2	51	Q86YR7
IAGPGLGSGVRARVL	FLNB	1426	O75369
NGLGIRIVGGKEIPG	PCLO	4511	Q9Y6V0
LTLPAIVGIGGGGGL	PLXNA1	1241	Q9UIW2
ETGPLGGGIRITILG	PLXNB2	811	O15031
GGGIRITILGSNLGV	PLXNB2	816	O15031
GPLDGGTLLTIRGRN	PLXND1	901	Q9Y4D7
IRGENLGTGPTDLIG	EXOC2	26	Q96KP1
GIERYELLQEPGGGG	PCDH7	176	O60245
GQGGSILGTKRVLPG	PFKP	471	Q01813
VLLVDEAGGSGRAGP	PTGER4	451	P35408
ISGTEGLRRLGGPQA	DECR2	211	Q9NUI1
VRGGAPGIEGTGLEQ	EHBP1L1	511	Q8N3D4
VQLVESGGGVVRPGG	IGHV3-20	21	A0A0C4DH32
SGGGLVQPGGSLRLS	IGHV3-64D	26	A0A0J9YX35
QGGGGLGLETLPALE	NALF2	451	O75949
SGGGLVQPGGSLRLS	IGHV3-74	26	A0A0B4J1X5
GRILIGGNLPGSSGR	PADI3	426	Q9ULW8
LVFGARGVGLGSGAP	PAQR4	186	Q8N4S7
GLGSRGNISLGPGET	NUTM1	761	Q86Y26
EEVLGGGGQGRLLGS	PIK3C2B	211	O00750
IITLVRGSGEGGPQG	GPRC5C	176	Q9NQ84
LGEGAELGARGQSLP	MRGPRG	271	Q86SM5
EPGVGREGLLGGRNV	NR0B1	46	P51843
RVGHLVLIGGPDDGV	PPT2	216	Q9UMR5
GGDPRRITVFGSGIG	NLGN3	276	Q9NZ94
RSGARLLVLEGGAPG	GASK1B	241	Q6UWH4
FPGGSLLLAGRSGVG	DYNC2H1	2646	Q8NCM8
GGGGSRTLVSGLLLE	FOXO3B	166	A0A2Z4LIS9
RPGEVLGLVGTNGIG	ABCE1	101	P61221
LVGGLAGPGGARRTV	GRID2IP	266	A4D2P6
VLRLTGRGGGGTVVG	GIGYF2	101	Q6Y7W6
GSGPRSGLGELILPE	FH	346	P07954
TGITIGEKGNIGLPG	COL4A5	351	P29400
LIGEQGISGPRGSGG	COL6A3	2241	P12111
LDCGSGPGILGISGR	FAT3	3896	Q8TDW7
GPGILGISGRAVNDG	FAT3	3901	Q8TDW7
GEVAGGGTPLLIAAR	FEM1A	36	Q9BSK4
GLGRLRVPTGEGAGI	CYP11A1	26	P05108
LIGQRGEPGLEGDSG	COL27A1	1181	Q8IZC6
VVGRQGLEGIAGPDG	COL27A1	1431	Q8IZC6
KPGLRGEIGEQGLAG	COL22A1	781	Q8NFW1
SGGGLVQPGGSLRLS	IGHV3-23	26	P01764
PGEGVGLLGTGREGT	MAP3K12	671	Q12852
ALARITGIGLGGRAP	ANKS3	271	Q6ZW76
LLPTGAEAGEIIGGR	CTSG	11	P08311
PLGIAGITGARGLAG	COL3A1	946	P02461
VGAGGQGPIITGLTI	FBN2	476	P35556
GPSLGGLGLGLAGRV	GLIS1	176	Q8NBF1
SGGGLVQPGGSLRLS	IGHV3-16	26	A0A0C4DH30
GSGDLVGSEQLLRGP	COL15A1	606	P39059
SGPGGVRVGALLLLG	EFNB3	6	Q15768
GGVPRTAAGGVGTLL	NLRP6	516	P59044
PEGTILGLRLDSSGG	NEURL4	1241	Q96JN8
ILGTGQRGPGAELDV	CD22	401	P20273
IRVLLTRPGEGGTGL	PTPRK	361	Q15262
TGGGLIQPGGSLRLS	IGHV3-53	26	P01767
SGGGLVQPGGSLRLS	IGHV3-35	26	A0A0C4DH35
IIRIGTSGGIGLEPG	UPP1	136	Q16831
GGLGPLGQKTARTLG	SYNE4	256	Q8N205
LLSLGGGAGVAVAPG	TMEM229A	141	B2RXF0
VLLTLGLVGPCGVGG	SLC22A17	131	Q8WUG5
GQAVGTRRGSPLLIG	GFPT1	196	Q06210
PQSGLGRHLGVVIGI	LILRB1	451	Q8NHL6
VELGPGRGTLVGDIL	NDUFAF7	121	Q7L592
SDILGRPVGAAGGGL	NKX6-2	61	Q9C056
VPGVGELFGGGLREE	NARS2	396	Q96I59
LTRGPSGLGFNIVGG	SYNJ2BP	16	P57105
DRVEGGSPTLGLLGG	ITPKB	441	P27987
GSGLIREDPIGAGAL	MT-ND6	131	P03923
TLGGNLTVAVGPLGR	SH3YL1	121	Q96HL8
RPVSGVLLGAVGGAG	SIGLEC7	346	Q9Y286
PLGIGLGLGIESAQG	SLC39A3	241	Q9BRY0
PGGALGQLLGGVIVS	SLCO6A1	431	Q86UG4
LPVLEGLGPSLGGGT	SCARB1	536	Q8WTV0
GGPEIELIAIATGGR	CCT5	326	P48643
GPRDILDGRGGISGT	WIZ	56	O95785
IGGLLLVVALGPGGV	SURF4	246	O15260
ILRQTGGLGISIAGG	SCRIB	731	Q14160
LPGIIEGAAQGKGRG	DRG2	116	P55039
AGSGQEGTRGLLPLR	NINL	836	Q9Y2I6
LGRGVPAGGSGLALS	OXCT2	11	Q9BYC2
PGALVLAVGGGGLLA	SDSL	166	Q96GA7
GQALPGVGELLGTQR	SPTBN5	2816	Q9NRC6
GLGGAVLGVGLSLGP	SLC39A5	456	Q6ZMH5
RGSRGPDGLLGEQGI	COL24A1	926	Q17RW2
GHRGNTGPLGREGII	COL24A1	1426	Q17RW2
GIVEPRVGGGLGSRA	ZCCHC2	241	Q9C0B9
GILVPGGFGIRGTLG	CTPS2	366	Q9NRF8
IGRQEFLLAGPGGLG	TGFBRAP1	216	Q8WUH2
GRGEVGADLPGSLSL	TICRR	1701	Q7Z2Z1
EGLLLIPGGRASVGA	ZBTB12	276	Q9Y330
GVVGGLSGGALSPLR	TFE3	531	P19532
RTVQGAEGGLGPGLS	RP1L1	1721	Q8IWN7
VEESGLGLGLGPGRS	SOWAHA	261	Q2M3V2
ILSRGGFLGEGPGDT	SLC26A1	656	Q9H2B4
GLEGPGGLEGRLQAT	IGSF9B	936	Q9UPX0
ALGISIAGGRGSPLG	PATJ	1686	Q8NI35
GRGELRGLVVPSGAE	TEX54	46	A0A1B0GVG6
GGIIGALLGTPVGGL	TIMMDC1	191	Q9NPL8
GVGPVLSEGLRRLAG	VWA2	666	Q5GFL6
LISRSLGPELGGSIG	SLC12A3	206	P55017
LGGERRPGVTAGILE	TACC2	1656	O95359
KVLIIGGGDGGVLRE	SRM	96	P19623
LVGGGRFLQGRGPSE	SKOR2	781	Q2VWA4
GGAGLELHPLLGGRT	PRSS3	41	P35030
GQESGPLRIGIGFGL	PRR30	286	Q53SZ7
TGGLRGIARGGLTGL	TIMM23	171	O14925
GRLGLPGEAGLEGSE	KMT2D	1616	O14686
VGGRTLTVSVGDGLP	MYO1F	906	O00160